{"componentChunkName":"component---src-templates-topic-topic-tsx","path":"/topics/conjunctivitis-allergic/","result":{"data":{"firstChapter":{"id":"bc756208-c2a7-5b33-a4cb-67c41a75ecb0","slug":"summary","fullItemName":"Summary","subChapters":[],"depth":1,"htmlHeader":"<!-- begin field 832b0917-05fc-4f37-a0f5-c1a59debd872 --><h1>Conjunctivitis - allergic: Summary</h1><!-- end field 832b0917-05fc-4f37-a0f5-c1a59debd872 -->","htmlStringContent":"<!-- begin item 1a5998f6-8304-483c-9af0-54f5c6bef7e1 --><!-- begin field 32fb0fae-c833-46f4-aa75-a8bbbf603429 --><ul><li>Allergic conjunctivitis is a term used to describe a group of ocular conditions associated with an immunoglobulin E (IgE) hypersensitivity reaction including:<ul><li>Seasonal allergic conjunctivitis — occurs periodically and is associated with seasonal allergens (such as tree and grass pollen).</li><li>Perennial allergic conjunctivitis — associated with non-seasonal environmental allergens often found in the home (such as house dust mites, mould spores or animal dander).</li><li>Vernal keratoconjunctivitis — commonest and most severe in hot arid environments (such as the Mediterranean, West Africa and India).</li><li>Atopic keratoconjunctivitis — severe and usually associated with atopic dermatitis of the eyelids.</li><li>Giant papillary conjunctivitis — also has a mechanical component and can occur as a result of chronic micro-trauma (for example from contact lens wear, ocular prostheses or ocular sutures).</li></ul></li><li>In most cases (excluding vernal and atopic keratoconjunctivitis) conjunctivitis does not cause permanent visual loss or structural damage.</li><li>The most consistent clinical feature of allergic conjunctivitis is itching. Other features include watery or mucoid discharge, conjunctival redness (injection) and oedema of the conjunctiva (chemosis) and eyelid.</li><li>Serious causes of red eye (such as acute glaucoma, corneal ulcer, keratitis, iritis, scleritis and trauma) must be excluded — urgent referral to ophthalmology is required if any red flag features (such as pain, photophobia, change in visual acuity and pupillary abnormality) are present.<ul><li>Urgent referral to ophthalmology is also required if the person has a systemic disease associated with eye symptoms (such as rheumatoid arthritis or Sjogren's syndrome), wears contact lenses and corneal involvement is suspected or a neonate presents with a red sticky eye. </li></ul></li><li>Ophthalmology should be consulted (with urgency dependent on the clinical situation) if there is diagnostic uncertainty, appropriate equipment is not available, atopic or vernal keratoconjunctivitis is suspected or the person has severe or treatment-resistant allergic conjunctivitis.</li><li>Management in primary care includes:<ul><li>Provision of patient information on allergic conjunctivitis.</li><li>Self care advice on avoidance of allergens and eye rubbing, application of cold compresses and ocular surface lubricants.</li><li>Consideration of topical antihistamines, mast cell stabilizers or dual action antihistamine and mast cell stabilizing eye drops.</li><li>Follow up and appropriate safety netting on red flag clinical features that indicate the need for urgent review in the interim.</li></ul></li></ul><!-- end field 32fb0fae-c833-46f4-aa75-a8bbbf603429 --><!-- end item 1a5998f6-8304-483c-9af0-54f5c6bef7e1 -->","topic":{"id":"b4698c45-6b7c-5244-836f-430591327957","topicId":"27f540e5-bb8e-4cee-a0aa-be515efa4fc2","topicName":"Conjunctivitis - allergic","slug":"conjunctivitis-allergic","aliases":[],"chapters":[{"id":"bc756208-c2a7-5b33-a4cb-67c41a75ecb0","slug":"summary","fullItemName":"Summary","subChapters":[]},{"id":"6470bf56-596c-5d66-b2b2-ba79590bb255","slug":"have-i-got-the-right-topic","fullItemName":"Have I got the right topic?","subChapters":[]},{"id":"17755f2a-0980-50f9-b62e-a34968c9682e","slug":"how-up-to-date-is-this-topic","fullItemName":"How up-to-date is this topic?","subChapters":[{"id":"b1dc6613-43b4-55fe-9216-a83aab0ef918","slug":"changes","fullItemName":"Changes"},{"id":"ba5e8d6b-90f7-5b69-b09a-2bb0c2692918","slug":"update","fullItemName":"Update"}]},{"id":"fee1ca82-9d2a-50a4-9230-1a93482b8b4f","slug":"goals-outcome-measures","fullItemName":"Goals and outcome measures","subChapters":[{"id":"3d036930-da50-5ea2-82e1-1d0fb936a8b4","slug":"goals","fullItemName":"Goals"},{"id":"9ba6a0ce-0eae-5442-85f0-81f7ff71345b","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"48935dfe-bca1-53fa-8d50-fa978331bd56","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"35b962f0-ec6b-53c9-b6f2-a5783ae10716","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"8e9984f4-8c0d-5231-9eec-91a9fb49ecc4","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"8fa3b231-6e2b-5fa2-aa0c-eb5359ff8160","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"ebf46a5d-2a79-5df8-82dd-d23fcb0559f1","slug":"background-information","fullItemName":"Background information","subChapters":[{"id":"67185462-9d0a-5b7d-b8af-80b8958f2420","slug":"definition","fullItemName":"Definition"},{"id":"1c320f1a-b91f-5d5b-a47b-dc0094518883","slug":"prevalence","fullItemName":"Prevalence"},{"id":"b21baf96-f39b-5eeb-934b-c193a434933d","slug":"causes","fullItemName":"Causes"},{"id":"923b6415-5fe1-550a-baf5-89285f8ddf77","slug":"complications","fullItemName":"Complications"},{"id":"a679bff6-4749-539e-bdb0-a762a9f91728","slug":"prognosis","fullItemName":"Prognosis"}]},{"id":"a7d99d63-f47f-54bf-a60f-8ae6f2a42fb9","slug":"diagnosis","fullItemName":"Diagnosis","subChapters":[{"id":"089d5cf7-0f6b-521b-88c1-d4f25eef7101","slug":"assessment","fullItemName":"Assessment"},{"id":"7bb8bdb4-0279-5783-ba21-e44e8bcd0832","slug":"clinical-features","fullItemName":"Clinical features"},{"id":"9a95dbd6-aaa4-5d6a-aa5b-9635d279f9a0","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"51e7c1d5-cd3d-5dea-a8ec-5a38deb58245","slug":"management","fullItemName":"Management","subChapters":[{"id":"e4ced49a-4b06-5559-9efb-c708812a8065","slug":"referral","fullItemName":"Scenario: Referral"},{"id":"77a507ec-4dff-5204-b375-121264b0adf8","slug":"management-in-primary-care","fullItemName":"Scenario: Management in primary care"}]},{"id":"452bc42e-1fe8-56e6-8511-57362d05fe3f","slug":"prescribing-information","fullItemName":"Prescribing information","subChapters":[{"id":"f9e89c16-d4a7-5241-86f6-1f78eacc68fa","slug":"topical-ocular-antihistamines-mast-cell-stabilizers","fullItemName":"Topical ocular antihistamines and mast cell stabilizers"},{"id":"f9a1678c-7117-5852-af35-628b676780c8","slug":"mast-cell-stabilizers","fullItemName":"Mast cell stabilizers"}]},{"id":"a32b7db8-1764-58b8-adbb-ab8ce0f44e46","slug":"supporting-evidence","fullItemName":"Supporting evidence","subChapters":[]},{"id":"bd1a2d20-e91f-51f1-a2a2-486ebf015f65","slug":"how-this-topic-was-developed","fullItemName":"How this topic was developed","subChapters":[{"id":"bc4e76de-c203-5f3e-ad9a-b84d6bc9d81e","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"565b3a01-b21e-5837-b9f1-49fda55982ad","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"b08973ef-af46-5e6f-b85c-d0bd9ca40bab","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"3003e52e-8597-505e-a3ce-e46fde4c0c20","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"b7947929-e2f9-50c7-b5cd-3e34b802bae1","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"3819cbbb-ca8c-58b7-b608-0a9567c5d5b5","slug":"references","fullItemName":"References","subChapters":[]}]}},"topic":{"id":"b4698c45-6b7c-5244-836f-430591327957","topicId":"27f540e5-bb8e-4cee-a0aa-be515efa4fc2","topicName":"Conjunctivitis - allergic","slug":"conjunctivitis-allergic","aliases":[],"topicSummary":"Allergic conjunctivitis is a term used to describe a group of ocular conditions associated with an immunoglobulin E (IgE) hypersensitivity reaction","lastRevised":"Last revised in October 2020","nextPlannedReviewBy":"2022-05-01T00:00:00+01:00","nextPlannedReviewByDateTime":"2022-04","nextPlannedReviewByDisplay":"April 2022","specialities":[{"id":"861c4fe3-02c7-51e0-8f03-a114c375ba4d","name":"Allergies","slug":"allergies"},{"id":"485bdd1b-4437-5374-838e-f1f1db61a424","name":"Eyes","slug":"eyes"}],"chapters":[{"id":"bc756208-c2a7-5b33-a4cb-67c41a75ecb0","slug":"summary","fullItemName":"Summary","subChapters":[]},{"id":"6470bf56-596c-5d66-b2b2-ba79590bb255","slug":"have-i-got-the-right-topic","fullItemName":"Have I got the right topic?","subChapters":[]},{"id":"17755f2a-0980-50f9-b62e-a34968c9682e","slug":"how-up-to-date-is-this-topic","fullItemName":"How up-to-date is this topic?","subChapters":[{"id":"b1dc6613-43b4-55fe-9216-a83aab0ef918","slug":"changes","fullItemName":"Changes"},{"id":"ba5e8d6b-90f7-5b69-b09a-2bb0c2692918","slug":"update","fullItemName":"Update"}]},{"id":"fee1ca82-9d2a-50a4-9230-1a93482b8b4f","slug":"goals-outcome-measures","fullItemName":"Goals and outcome measures","subChapters":[{"id":"3d036930-da50-5ea2-82e1-1d0fb936a8b4","slug":"goals","fullItemName":"Goals"},{"id":"9ba6a0ce-0eae-5442-85f0-81f7ff71345b","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"48935dfe-bca1-53fa-8d50-fa978331bd56","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"35b962f0-ec6b-53c9-b6f2-a5783ae10716","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"8e9984f4-8c0d-5231-9eec-91a9fb49ecc4","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"8fa3b231-6e2b-5fa2-aa0c-eb5359ff8160","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"ebf46a5d-2a79-5df8-82dd-d23fcb0559f1","slug":"background-information","fullItemName":"Background information","subChapters":[{"id":"67185462-9d0a-5b7d-b8af-80b8958f2420","slug":"definition","fullItemName":"Definition"},{"id":"1c320f1a-b91f-5d5b-a47b-dc0094518883","slug":"prevalence","fullItemName":"Prevalence"},{"id":"b21baf96-f39b-5eeb-934b-c193a434933d","slug":"causes","fullItemName":"Causes"},{"id":"923b6415-5fe1-550a-baf5-89285f8ddf77","slug":"complications","fullItemName":"Complications"},{"id":"a679bff6-4749-539e-bdb0-a762a9f91728","slug":"prognosis","fullItemName":"Prognosis"}]},{"id":"a7d99d63-f47f-54bf-a60f-8ae6f2a42fb9","slug":"diagnosis","fullItemName":"Diagnosis","subChapters":[{"id":"089d5cf7-0f6b-521b-88c1-d4f25eef7101","slug":"assessment","fullItemName":"Assessment"},{"id":"7bb8bdb4-0279-5783-ba21-e44e8bcd0832","slug":"clinical-features","fullItemName":"Clinical features"},{"id":"9a95dbd6-aaa4-5d6a-aa5b-9635d279f9a0","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"51e7c1d5-cd3d-5dea-a8ec-5a38deb58245","slug":"management","fullItemName":"Management","subChapters":[{"id":"e4ced49a-4b06-5559-9efb-c708812a8065","slug":"referral","fullItemName":"Scenario: Referral"},{"id":"77a507ec-4dff-5204-b375-121264b0adf8","slug":"management-in-primary-care","fullItemName":"Scenario: Management in primary care"}]},{"id":"452bc42e-1fe8-56e6-8511-57362d05fe3f","slug":"prescribing-information","fullItemName":"Prescribing information","subChapters":[{"id":"f9e89c16-d4a7-5241-86f6-1f78eacc68fa","slug":"topical-ocular-antihistamines-mast-cell-stabilizers","fullItemName":"Topical ocular antihistamines and mast cell stabilizers"},{"id":"f9a1678c-7117-5852-af35-628b676780c8","slug":"mast-cell-stabilizers","fullItemName":"Mast cell stabilizers"}]},{"id":"a32b7db8-1764-58b8-adbb-ab8ce0f44e46","slug":"supporting-evidence","fullItemName":"Supporting evidence","subChapters":[]},{"id":"bd1a2d20-e91f-51f1-a2a2-486ebf015f65","slug":"how-this-topic-was-developed","fullItemName":"How this topic was developed","subChapters":[{"id":"bc4e76de-c203-5f3e-ad9a-b84d6bc9d81e","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"565b3a01-b21e-5837-b9f1-49fda55982ad","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"b08973ef-af46-5e6f-b85c-d0bd9ca40bab","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"3003e52e-8597-505e-a3ce-e46fde4c0c20","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"b7947929-e2f9-50c7-b5cd-3e34b802bae1","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"3819cbbb-ca8c-58b7-b608-0a9567c5d5b5","slug":"references","fullItemName":"References","subChapters":[]}]}},"pageContext":{"id":"b4698c45-6b7c-5244-836f-430591327957"}},"staticQueryHashes":["3666801979"]}